Lipocine, Inc. (LPCN)
1.54
+0.01
(+0.65%)
USD |
NASDAQ |
Nov 06, 09:58
Lipocine Max Drawdown (5Y) : 95.83% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 95.83% |
| September 30, 2026 | 95.83% |
| August 31, 2026 | 95.83% |
| July 31, 2026 | 95.83% |
| June 30, 2026 | 95.83% |
| May 31, 2026 | 95.83% |
| April 30, 2026 | 95.83% |
| March 31, 2026 | 95.83% |
| February 28, 2026 | 95.83% |
| January 31, 2026 | 95.83% |
| December 31, 2025 | 95.83% |
| November 30, 2025 | 95.83% |
| October 31, 2025 | 95.83% |
| September 30, 2025 | 95.83% |
| August 31, 2025 | 95.83% |
| July 31, 2025 | 95.83% |
| June 30, 2025 | 95.83% |
| May 31, 2025 | 95.83% |
| April 30, 2025 | 96.93% |
| March 31, 2025 | 97.76% |
| February 28, 2025 | 98.27% |
| January 31, 2025 | 98.27% |
| December 31, 2024 | 98.27% |
| November 30, 2024 | 98.27% |
| October 31, 2024 | 98.27% |
| Date | Value |
|---|---|
| September 30, 2024 | 98.27% |
| August 31, 2024 | 98.27% |
| July 31, 2024 | 98.27% |
| June 30, 2024 | 98.27% |
| May 31, 2024 | 98.27% |
| April 30, 2024 | 98.27% |
| March 31, 2024 | 98.27% |
| February 29, 2024 | 98.27% |
| January 31, 2024 | 98.27% |
| December 31, 2023 | 98.27% |
| November 30, 2023 | 98.27% |
| October 31, 2023 | 98.27% |
| September 30, 2023 | 98.27% |
| August 31, 2023 | 98.27% |
| July 31, 2023 | 98.27% |
| June 30, 2023 | 98.45% |
| May 31, 2023 | 98.62% |
| April 30, 2023 | 98.77% |
| March 31, 2023 | 98.77% |
| February 28, 2023 | 98.77% |
| January 31, 2023 | 98.77% |
| December 31, 2022 | 98.77% |
| November 30, 2022 | 98.77% |
| October 31, 2022 | 98.77% |
| September 30, 2022 | 98.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Johnson & Johnson | 18.44% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
| Eli Lilly & Co. | 34.47% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.34 |
| Beta (5Y) | 0.4927 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 103.6% |
| Historical Sharpe Ratio (5Y) | -0.4178 |
| Historical Sortino (5Y) | -0.882 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.85% |